150 related articles for article (PubMed ID: 12409341)
1. Unusual sites of involvement in non-Hodgkin's lymphoma: Case 3. Intussusception as a rare complication of mantle-cell lymphoma.
Sucker C; Klima KM; Doelken G; Heidecke CD; Lorenz G; Stockschlaeder M
J Clin Oncol; 2002 Nov; 20(21):4397-8. PubMed ID: 12409341
[No Abstract] [Full Text] [Related]
2. Mantle cell lymphoma as a rare cause of intussusception: a report of 2 cases.
Grin A; Chetty R; Bailey D
Ann Diagn Pathol; 2009 Dec; 13(6):398-401. PubMed ID: 19917477
[TBL] [Abstract][Full Text] [Related]
3. Primary colon mantle lymphoma: a misleading macroscopic appearance!
Arieira C; Dias de Castro F; Boal Carvalho P; Cotter J
Rev Esp Enferm Dig; 2019 Dec; 111(12):965-967. PubMed ID: 31663363
[TBL] [Abstract][Full Text] [Related]
4. Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract.
Michopoulos S; Petraki K; Matsouka C; Kastritis E; Chrysanthopoulou H; Dimopoulos MA
J Clin Oncol; 2008 Mar; 26(9):1555-7. PubMed ID: 18349408
[No Abstract] [Full Text] [Related]
5. Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
Ruan J; Martin P; Furman RR; Lee SM; Cheung K; Vose JM; Lacasce A; Morrison J; Elstrom R; Ely S; Chadburn A; Cesarman E; Coleman M; Leonard JP
J Clin Oncol; 2011 Feb; 29(6):690-7. PubMed ID: 21189393
[TBL] [Abstract][Full Text] [Related]
6. Lymphomatous polyposis as primary manifestation of mantle cell lymphoma.
Yu SC; Liu KL; Chang LC
Eur J Haematol; 2012 Aug; 89(2):185-6. PubMed ID: 22563740
[No Abstract] [Full Text] [Related]
7. [Recent progress in the therapeutic strategy for follicular lymphoma and mantle cell lymphoma].
Ogura M
Rinsho Ketsueki; 2006 Jun; 47(6):495-512. PubMed ID: 16862978
[No Abstract] [Full Text] [Related]
8. A rare case of nasal Mantle cell lymphoma.
Dahanayake G; Rokade A; Ghosh S; Raut V
Kulak Burun Bogaz Ihtis Derg; 2010; 20(1):44-7. PubMed ID: 20163337
[TBL] [Abstract][Full Text] [Related]
9. Bilateral endobronchial involvement in mantle cell lymphoma.
Miyoshi I; Togitani K; Kuwayama Y; Daibata M; Matsumoto M; Taguchi H
Intern Med; 2007; 46(7):429-30. PubMed ID: 17409613
[No Abstract] [Full Text] [Related]
10. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM
Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771
[TBL] [Abstract][Full Text] [Related]
11. Unusual sites of involvement in non-Hodgkin's lymphoma: Case 2. Isolated meningeal anaplastic large-cell lymphoma.
Aloulou S; Bosq J; Vanel D; Ribrag V
J Clin Oncol; 2002 Nov; 20(21):4395-7. PubMed ID: 12409340
[No Abstract] [Full Text] [Related]
12. Mantle cell lymphoma: a great masquerader.
Paludo J; Kapoor P; Oliveira JL; Garrity JA; Nowakowski GS
Int J Hematol; 2014 Oct; 100(4):313-4. PubMed ID: 25073863
[No Abstract] [Full Text] [Related]
13. Chemotherapy as treatment for colo-colonic intussusception associated with acquired immune deficiency syndrome-related lymphoma.
Lerner A; Soto J; Rosen JE
Surgery; 2011 May; 149(5):726-7. PubMed ID: 19962169
[No Abstract] [Full Text] [Related]
14. Unusual cause of adult intussusception: diffuse large B-cell non-Hodgkin's lymphoma: a case report and review.
Akbulut S
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1938-46. PubMed ID: 23242720
[TBL] [Abstract][Full Text] [Related]
15. Correspondence re: Viswanatha DS, Foucar K, Berry BR, Gascoyne RD, Evans HL, Leith CP. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma. Mod Pathol 2000;13:825-33.
Dunphy CH
Mod Pathol; 2001 Mar; 14(3):263-4. PubMed ID: 11266537
[No Abstract] [Full Text] [Related]
16. A rare case of small bowel intussusception.
Murino A; Despott EJ; Hansmann A; Heath P; Fraser C
Endoscopy; 2012; 44 Suppl 2 UCTN():E157-8. PubMed ID: 22622719
[No Abstract] [Full Text] [Related]
17. Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma.
Hess G; Flohr T; Huber C; Kolbe K; Derigs HG; Fischer T
Bone Marrow Transplant; 2003 May; 31(9):775-82. PubMed ID: 12732884
[TBL] [Abstract][Full Text] [Related]
18. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
19. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Rummel MJ; Niederle N; Maschmeyer G; Banat GA; von Grünhagen U; Losem C; Kofahl-Krause D; Heil G; Welslau M; Balser C; Kaiser U; Weidmann E; Dürk H; Ballo H; Stauch M; Roller F; Barth J; Hoelzer D; Hinke A; Brugger W;
Lancet; 2013 Apr; 381(9873):1203-10. PubMed ID: 23433739
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2005 Jun; (13):1-18. PubMed ID: 16135258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
